![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/02/07/2825615/0/en/Mydecine-Innovations-Group-Receives-Two-Notice-of-Allowances-from-USPTO-for-its-MYCO-005-and-MYCO-006-Family-of-Compounds.html
https://www.globenewswire.com//news-release/2023/11/28/2787361/0/en/Mydecine-Announces-Update-Regarding-the-Special-Access-Program.html
https://www.globenewswire.com//news-release/2023/10/31/2769817/0/en/Mydecine-Innovations-Group-Files-Prospectus-Supplement-Announces-Closing-Under-Share-Subscription-Agreements.html
https://www.globenewswire.com//news-release/2023/10/26/2767127/0/en/Mydecine-Provides-Q4-2023-Business-Update.html
https://www.globenewswire.com//news-release/2023/10/12/2758940/0/en/Mydecine-Innovations-Group-Announces-Admission-to-Trading-on-the-AQSE-Growth-Market-in-London-UK.html
https://www.globenewswire.com//news-release/2023/10/10/2757124/0/en/Mydecine-Innovations-Group-Announces-Admission-to-Trading-on-the-AQSE-Growth-Market-in-London-UK-and-First-Day-of-Dealings.html
https://www.globenewswire.com//news-release/2023/10/05/2755826/0/en/Mydecine-Innovations-Group-Announces-Listing-on-the-Canadian-Securities-Exchange-and-Delisting-from-the-NEO.html
https://www.globenewswire.com//news-release/2023/09/27/2750787/0/en/Mydecine-Innovations-Group-Announces-Expected-U-K-Dual-Listing-Admission-Date.html
https://www.globenewswire.com//news-release/2023/09/19/2746008/0/en/Mydecine-Innovations-Announces-Closing-of-Prospectus-Supplement-Financing.html
https://www.globenewswire.com//news-release/2023/09/15/2744268/0/en/Mydecine-Innovations-Group-Files-Prospectus-Supplement.html